首页> Cancer immunology, immunotherapy : CII> Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.

Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.

导出 OA

翻译打印收藏纠错

第一作者： Chengpei,Zhu

第一单位： Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), #1 Shuaifuyuan, Wangfujing, Beijing, 100730, China.

作者： Chengpei,Zhu ^[1] ; Hu,Li ^[2] ; Xiaobo,Yang ^[1] ; Shanshan,Wang ^[1] ; Yunchao,Wang ^[1] ; Nan,Zhang ^[1] ; Yanyu,Wang ^[1] ; Jingnan,Xue ^[1] ; Longhao,Zhang ^[1] ; Cong,Ning ^[1] ; Xu,Yang ^[1] ; Ziyu,Xun ^[1] ; Jiashuo,Chao ^[1] ; Junyu,Long ^[1] ; Xinting,Sang ^[3] ; Zhenyu,Zhu ^[4] ; Haitao,Zhao ^[5]

作者单位： Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), #1 Shuaifuyuan, Wangfujing, Beijing, 100730, China. ^[1] Department of Hepatobiliary Surgery, The Fifth Medical Center of PLA General Hospital, No. 100 Middle Road of West 4th Ring Road, Fengtai District, Beijing, 100039, China. ^[2] Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), #1 Shuaifuyuan, Wangfujing, Beijing, 100730, China. sangxt@pumch.cn. ^[3] Department of Hepatobiliary Surgery, The Fifth Medical Center of PLA General Hospital, No. 100 Middle Road of West 4th Ring Road, Fengtai District, Beijing, 100039, China. zhuzy302@163.com. ^[4] Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), #1 Shuaifuyuan, Wangfujing, Beijing, 100730, China. zhaoht@pumch.cn. ^[5]

关键词 Advanced intrahepatic cholangiocarcinoma Gemox chemotherapy Lenvatinib PD-1 inhibitor Systemic therapy

医学主题词人类(Humans);回顾性研究(Retrospective Studies);预后(Prognosis);胆管上皮癌(Cholangiocarcinoma);胆管肿瘤(Bile Duct Neoplasms);胆管, 肝内(Bile Ducts, Intrahepatic)

DOI 10.1007/s00262-023-03466-8

PMID 37247023

发布时间 2024-09-26

基金项目